Cardiology · Internal Medicine

CHA2DS2-VA (without sex) calculator

Enter the published formula inputs below to calculate and interpret this score.

Clinical inputs

Chronic heart failure (+1)Hypertension (+1)

Age

Diabetes mellitus (+1)Prior stroke, TIA or arterial thromboembolism (+2)Vascular disease (+1)

Result

1 field remaining

Anyone can run this calculator. Sign in to save, favourite, or send the result.

Professional use only

For qualified clinicians. Independently verify inputs, calculations, source guidance, and applicability before any clinical action. This calculator does not replace clinical judgment.

Source: Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314-3414 (Table 10, CHA2DS2-VA). DOI: 10.1093/eurheartj/ehae176. PMID: 39210723. Scope: CHA2DS2-VA points: chronic heart failure +1, hypertension +1, age ≥75 years +2, diabetes mellitus +1, prior stroke/TIA/arterial thromboembolism +2, vascular disease +1, age 65–74 years +1 (maximum 8; sex is not scored). ESC 2024: oral anticoagulation is recommended with a score of 2 or more and should be considered with a score of 1. Derived from CHA2DS2-VASc (Lip GYH et al. Chest 2010;137:263-272). (2024)

Ruqelo is AI and can make mistakes. Check important information.

Clinical inputs

Chronic heart failure (+1)
Hypertension (+1)
Age
Diabetes mellitus (+1)
Prior stroke, TIA or arterial thromboembolism (+2)
Vascular disease (+1)

Primary source

Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314-3414 (Table 10, CHA2DS2-VA). DOI: 10.1093/eurheartj/ehae176. PMID: 39210723. Scope: CHA2DS2-VA points: chronic heart failure +1, hypertension +1, age ≥75 years +2, diabetes mellitus +1, prior stroke/TIA/arterial thromboembolism +2, vascular disease +1, age 65–74 years +1 (maximum 8; sex is not scored). ESC 2024: oral anticoagulation is recommended with a score of 2 or more and should be considered with a score of 1. Derived from CHA2DS2-VASc (Lip GYH et al. Chest 2010;137:263-272). (2024)

View source